TRACY WILLIAM DOBBS MD NPI 1104826148

NPI Details

Tracy William Dobbs, MD is a medical oncology internal medicine in Knoxville, TN with 43 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Tracy William Dobbs, MD NPI is 1104826148. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MISSOURI, KANSAS CITY, SCHOOL OF MEDICINE
Graduation Year:1983

The provider's business location address is:

1415 OLD WEISGARBER RD STE 200
KNOXVILLE, TN
ZIP 37909-341
Phone: (865) 934-5800
Fax: (865) 934-5801

The NPI 1104826148 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Iron binding capacity (HCPCS:83550)
• Iron level (HCPCS:83540)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Protein measurement, serum (HCPCS:84165)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Magnesium level (HCPCS:83735)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection of drug or substance into vein (HCPCS:96374)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Collection of blood sample from implanted device (HCPCS:36591)
• Red blood count, automated test (HCPCS:85045)
• Folic acid level, serum (HCPCS:82746)
• Erythropoietin (protein) level (HCPCS:82668)
• Haptoglobin (serum protein) level (HCPCS:83010)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)

The enumeration date for this NPI number is 7/29/2005 and was last updated on 4/21/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: